Evidence map›Paper›PMID 35683762›Full record

ReviewNanomaterials (Basel, Switzerland)2022

Recent Research Progress in the Structure, Fabrication, and Application of MXene-Based Heterostructures.

Ruxue Yang, Xiyue Chen, Wei Ke, Xin Wu

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ruxue YangSchool of Chemical Engineering and Technology, Sun Yat-sen University, Zhuhai 519082, China.
Xiyue ChenSchool of Chemical Engineering and Technology, Sun Yat-sen University, Zhuhai 519082, China.
Wei KeSchool of Chemical Engineering and Technology, Sun Yat-sen University, Zhuhai 519082, China.
Xin WuSchool of Chemical Engineering and Technology, Sun Yat-sen University, Zhuhai 519082, China.

Funding

GuangDong Basic and Applied Basic Research Foundation 2021A1515111067the University-Industry Collaborative Education Program 202102009004
6 · The paper itself

Abstract

Two-dimensional (2D) materials have received increasing attention in the scientific research community owing to their unique structure, which has endowed them with unparalleled properties and significant application potential. However, the expansion of the applications of an individual 2D material is often limited by some inherent drawbacks. Therefore, many researchers are now turning their attention to combine different 2D materials, making the so-called 2D heterostructures. Heterostructures can integrate the merits of each component and achieve a complementary performance far beyond a single part. MXene, as an emerging family of 2D nanomaterials, exhibits excellent electrochemical, electronic, optical, and mechanical properties. MXene-based heterostructures have already been demonstrated in applications such as supercapacitors, sensors, batteries, and photocatalysts. Nowadays, increasing research attention is attracted onto MXene-based heterostructures, while there is less effort spent to summarize the current research status. In this paper, the recent research progress of MXene-based heterostructures is reviewed, focusing on the structure, common preparation methods, and applications in supercapacitors, sensors, batteries, and photocatalysts. The main challenges and future prospects of MXene-based heterostructures are also discussed to provide valuable information for the researchers involved in the field.

Indexed as

heterostructuresMXenetwo-dimensional materials

Identifiers

PMID35683762
PMCPMC9182788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.